O
ISEE

OrbiMed’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

OrbiMed’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,361,400
Closed -$13.1K – 150
2022
Q2 		$13.1K Buy
+1,361,400
New +$17.1M 0.24% 78
2020
Q4 		– Sell
-3,411,806
Closed -$19.2M – 161
2020
Q3 		$19.2M Buy
3,411,806
+161,806
+5% +$772K 0.24% 86
2020
Q2 		$16.6M Buy
3,250,000
+2,500,000
+333% +$10.4M 0.23% 82
2020
Q1 		$2.58M Sell
750,000
-250,000
-25% -$1.46M 0.04% 123
2019
Q4 		$8.58M Buy
+1,000,000
New +$3.57M 0.12% 85
2016
Q4 		– Sell
-1,166,200
Closed -$53.8M – 143
2016
Q3 		$53.8M Sell
1,166,200
-981,900
-46% -$55.4M 0.61% 51
2016
Q2 		$110M Buy
2,148,100
+53,600
+3% +$2.66M 1.14% 33
2016
Q1 		$88.5M Buy
2,094,500
+83,000
+4% +$4.23M 0.93% 34
2015
Q4 		$158M Buy
2,011,500
+88,000
+5% +$5.09M 1.43% 24
2015
Q3 		$77.9M Buy
1,923,500
+248,900
+15% +$13.2M 0.79% 39
2015
Q2 		$87.2M Buy
1,674,600
+6,000
+0.4% +$298K 0.73% 42
2015
Q1 		$77.6M Buy
1,668,600
+806,800
+94% +$41.9M 0.66% 44
2014
Q4 		$38.7M Buy
861,800
+523,000
+154% +$22M 0.37% 58
2014
Q3 		$13.2M Buy
+338,800
New +$13.3M 0.14% 90
2014
Q1 		– Sell
-34,500
Closed -$1.12M – 149
2013
Q4 		$1.12M Buy
+34,500
New +$1.02M 0.02% 113

Other funds holding ISEE

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

OrbiMed's ISEE Position: Q3 2022 in Review

OrbiMed sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2022, closing a stake of 1,361,400 shares — an estimated $13.1K sold.

OrbiMed first reported a position in ISEE in Q4 2013 and held it in 15 quarters. The position peaked at $158M in Q4 2015. 213 funds tracked by Wall St. Rank hold ISEE as of Q3 2022.

  • OrbiMed reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • OrbiMed sold 1,361,400 IVERIC bio, Inc. Common Stock shares in Q3 2022, an estimated $13.1K.
  • OrbiMed first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 15 quarters.
  • OrbiMed's IVERIC bio, Inc. Common Stock position peaked at $158M in Q4 2015.
  • 213 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2022.

Based on OrbiMed's 13F filing for Q3 2022, filed 14 Nov 2022.